News

13 research projects will be funded

13 research projects will be funded

The Spanish Research Agency published last Friday the provisional resolution for the R+D+i Projects 2020 call «Retos Investigación» and «Generación de Conocimiento». 13 projects by our researchers will be funded, receiving a total of 2 million euros. Congrats!

Barcelona Science Festival 2021

Barcelona Science Festival 2021

Last weekend, researchers from the Institute participated in the Barcelona Science Festival, organized by the City Council, which this year was part of the Science City Biennial. In a brief TED-Talk format, Dr. Roser Nadal talked about conduct disorders and Judith Sanchez explained what perineural networks are.

Grants for students of the PhD program in Neurosciences

Grants for students of the PhD program in Neurosciences

Students of the PhD in Neuroscience Official Progam can now apply for two different grants:

  • Travel grants to attending Scientific Meetings and Conferences within the present academic year. Application extended until June, 30th
  • Fellowship at the Albert Einstein College of Medicine. Apply until May, 30th

More info

Same drug can have opposite effects on memory according to sexual differences

Same drug can have opposite effects on memory according to sexual differences

An investigation led by the INc-UAB, carried out from the study of a drug that modifies the memory of fear, shows for the first time that the neural processes and behaviours related to the formation of memory can be opposite between male and female mice. The study, published in Nature Communications, has been developed in collaboration with other INc-UAB research groups and the IMIM. Read the article

Drug with antioxidant properties reverses cognitive impairment in mouse models of ageing

Drug with antioxidant properties reverses cognitive impairment in mouse models of ageing

An international team of researchers with the participation of Dr. Lydia Giménez-Llort evaluated the protective effects of Calcium dobesilate (CaD), a drug with antioxidant properties, for the treatment of cognitive disorders in physiological ageing. Results demonstrated in an animal model that weight loss, anxiety-like and cognitive impairments were reversed by the administration of the drug, while also inhibiting the oxidative stress in their brains. The study has been published in Antioxidants.

Schedule

12:00 h
Semipresencial: virtual i aula 107 Pavelló Docent de la Vall d'Hebron Semipresencial: virtual i aula 107 Pavelló Docent de la Vall d'Hebron

Videos



Publications

Nieto-Nicolau, N., López-Chicón, P., Fariñas, O., Bolívar, S., Udina, E., Navarro, X., Casaroli-Marano, R., & Vilarrodona, A. (2021).
Effective decellularization of human nerve matrix for regenerative medicine with a novel protocol
Cell and Tissue Research,
https://pubmed.ncbi.nlm.nih.gov/33471198/

Ferrer, M., Aguilera, M., & Martinez, V. (2021).
Effects of rifaximin on luminal and wall-adhered gut commensal microbiota in mice
International Journal of Molecular Sciences,
https://pubmed.ncbi.nlm.nih.gov/33419066/

Escartin C, Galea E, Lakatos A, O’Callaghan JP, Petzold GC, Serrano-Pozo A, Steinhäuser C, Volterra A, Carmignoto G, Agarwal A, Allen NJ, Araque A, Barbeito L, Barzilai A, Bergles DE, Bonvento G, Butt AM, Chen W-T, Cohen-Salmon M, et al. (2021).
Reactive astrocyte nomenclature, definitions, and future directions
Nat Neurosci ,
http://www.nature.com/articles/s41593-020-00783-4